• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎病毒糖蛋白介导的病毒感染需要CD81。

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.

作者信息

Zhang Jie, Randall Glenn, Higginbottom Adrian, Monk Peter, Rice Charles M, McKeating Jane A

机构信息

Center for the Study of Hepatitis C, Laboratory of Virology and Infectious Diseases, The Rockefeller University, New York, New York 10021, USA.

出版信息

J Virol. 2004 Feb;78(3):1448-55. doi: 10.1128/jvi.78.3.1448-1455.2004.

DOI:10.1128/jvi.78.3.1448-1455.2004
PMID:14722300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC321402/
Abstract

CD81 has been described as a putative receptor for hepatitis C virus (HCV); however, its role in HCV cell entry has not been characterized due to the lack of an efficient cell culture system. We have examined the role of CD81 in HCV glycoprotein-dependent entry by using a recently developed retroviral pseudotyping system. Human immunodeficiency virus (HIV) pseudotypes bearing HCV E1E2 glycoproteins show a restricted tropism for human liver cell lines. Although all of the permissive cell lines express CD81, CD81 expression alone is not sufficient to allow viral entry. CD81 is required for HIV-HCV pseudotype infection since (i) a monoclonal antibody specific for CD81 inhibited infection of susceptible target cells and (ii) silencing of CD81 expression in Huh-7.5 hepatoma cells by small interfering RNAs inhibited HIV-HCV pseudotype infection. Furthermore, expression of CD81 in human liver cells that were previously resistant to infection, HepG2 and HH29, conferred permissivity of HCV pseudotype infection. The characterization of chimeric CD9/CD81 molecules confirmed that the large extracellular loop of CD81 is a determinant for viral entry. These data suggest a functional role for CD81 as a coreceptor for HCV glycoprotein-dependent viral cell entry.

摘要

CD81被认为是丙型肝炎病毒(HCV)的假定受体;然而,由于缺乏有效的细胞培养系统,其在HCV细胞进入过程中的作用尚未得到明确。我们通过使用最近开发的逆转录病毒假型系统,研究了CD81在HCV糖蛋白依赖性进入过程中的作用。携带HCV E1E2糖蛋白的人类免疫缺陷病毒(HIV)假型对人肝细胞系表现出有限的嗜性。尽管所有允许感染的细胞系都表达CD81,但仅CD81的表达不足以允许病毒进入。CD81是HIV-HCV假型感染所必需的,因为(i)一种针对CD81的单克隆抗体抑制了易感靶细胞的感染,并且(ii)小干扰RNA使Huh-7.5肝癌细胞中的CD81表达沉默,从而抑制了HIV-HCV假型感染。此外,在先前对感染具有抗性的人肝细胞HepG2和HH29中表达CD81,赋予了HCV假型感染的易感性。嵌合CD9/CD81分子的特性证实,CD81的大细胞外环是病毒进入的决定因素。这些数据表明CD81作为HCV糖蛋白依赖性病毒细胞进入的共受体具有功能性作用。

相似文献

1
CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.丙型肝炎病毒糖蛋白介导的病毒感染需要CD81。
J Virol. 2004 Feb;78(3):1448-55. doi: 10.1128/jvi.78.3.1448-1455.2004.
2
Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.多种丙型肝炎病毒糖蛋白以依赖CD81的方式介导病毒感染。
J Virol. 2004 Aug;78(16):8496-505. doi: 10.1128/JVI.78.16.8496-8505.2004.
3
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles.丙型肝炎病毒糖蛋白介导假型逆转录病毒颗粒的pH依赖性细胞进入。
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7271-6. doi: 10.1073/pnas.0832180100. Epub 2003 May 21.
4
Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.丙型肝炎病毒进入细胞需要一组共受体,其中包括CD81四跨膜蛋白和SR-B1清道夫受体。
J Biol Chem. 2003 Oct 24;278(43):41624-30. doi: 10.1074/jbc.M305289200. Epub 2003 Aug 11.
5
Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection.丙型肝炎病毒E2糖蛋白与CD81的结合与物种对感染的易感性无关。
J Virol. 2000 Jul;74(13):5933-8. doi: 10.1128/jvi.74.13.5933-5938.2000.
6
Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding.剖析E2假定的CD81结合区域在介导丙型肝炎病毒(HCV)进入过程中的作用:假定的CD81结合区域1不参与CD81结合。
Virol J. 2008 Mar 20;5:46. doi: 10.1186/1743-422X-5-46.
7
CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.CD81 受体胞外大环之外的区域决定丙型肝炎病毒进入肝癌细胞。
Viruses. 2018 Apr 20;10(4):207. doi: 10.3390/v10040207.
8
The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.CD81细胞表面表达水平是丙型肝炎病毒有效进入宿主细胞的关键决定因素。
J Virol. 2007 Jan;81(2):588-98. doi: 10.1128/JVI.01534-06. Epub 2006 Nov 1.
9
Diverse CD81 proteins support hepatitis C virus infection.多种CD81蛋白支持丙型肝炎病毒感染。
J Virol. 2006 Nov;80(22):11331-42. doi: 10.1128/JVI.00104-06. Epub 2006 Aug 30.
10
CD81 is an entry coreceptor for hepatitis C virus.CD81是丙型肝炎病毒的一种进入共受体。
Proc Natl Acad Sci U S A. 2004 May 11;101(19):7270-4. doi: 10.1073/pnas.0402253101. Epub 2004 May 3.

引用本文的文献

1
CD81 is a receptor for equine arteritis virus (family: ).CD81是马动脉炎病毒(所属科: )的一种受体。
mBio. 2025 Jul 9;16(7):e0062325. doi: 10.1128/mbio.00623-25. Epub 2025 May 27.
2
Functional Role of Hepatitis C Virus NS5A in the Regulation of Autophagy.丙型肝炎病毒NS5A在自噬调节中的功能作用
Pathogens. 2024 Nov 8;13(11):980. doi: 10.3390/pathogens13110980.
3
CRISPR/Cas9 as a New Antiviral Strategy for Treating Hepatitis Viral Infections.CRISPR/Cas9 作为一种治疗肝炎病毒感染的新抗病毒策略。
Int J Mol Sci. 2023 Dec 26;25(1):334. doi: 10.3390/ijms25010334.
4
Role of Immunological Cells in Hepatocellular Carcinoma Disease and Associated Pathways.免疫细胞在肝细胞癌疾病及相关通路中的作用
ACS Pharmacol Transl Sci. 2023 Nov 8;6(12):1801-1816. doi: 10.1021/acsptsci.3c00216. eCollection 2023 Dec 8.
5
The matrix metalloproteinase ADAM10 supports hepatitis C virus entry and cell-to-cell spread via its sheddase activity.基质金属蛋白酶 ADAM10 通过其脱落酶活性支持丙型肝炎病毒进入和细胞间传播。
PLoS Pathog. 2023 Nov 15;19(11):e1011759. doi: 10.1371/journal.ppat.1011759. eCollection 2023 Nov.
6
Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?假型慢病毒载体:准备好转化为靶向癌症基因治疗了吗?
Genes Dis. 2022 Apr 2;10(5):1937-1955. doi: 10.1016/j.gendis.2022.03.007. eCollection 2023 Sep.
7
Exosomes Released by Influenza-Virus-Infected Cells Carry Factors Capable of Suppressing Immune Defense Genes in Naïve Cells.流感病毒感染细胞释放的外泌体携带能够抑制幼稚细胞中免疫防御基因的因子。
Viruses. 2022 Nov 30;14(12):2690. doi: 10.3390/v14122690.
8
Extracellular vesicles as personalized medicine.细胞外囊泡作为个性化医疗。
Mol Aspects Med. 2023 Jun;91:101155. doi: 10.1016/j.mam.2022.101155. Epub 2022 Nov 28.
9
WTAP Targets the METTL3 mA-Methyltransferase Complex to Cytoplasmic Hepatitis C Virus RNA to Regulate Infection.WTAP 靶向 METTL3 mA-甲基转移酶复合物到细胞质丙型肝炎病毒 RNA 以调节感染。
J Virol. 2022 Nov 23;96(22):e0099722. doi: 10.1128/jvi.00997-22. Epub 2022 Oct 31.
10
Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV.利用具有有效直接病毒杀灭和抗 HCV 和 HSV 复制潜力的 Natrialba sp. M6 生产生物表面活性剂的生物工艺开发。
Sci Rep. 2022 Oct 4;12(1):16577. doi: 10.1038/s41598-022-20091-0.

本文引用的文献

1
Characterisation of the differences between hepatitis C virus genotype 3 and 1 glycoproteins.丙型肝炎病毒3型和1型糖蛋白差异的特征分析。
J Med Virol. 2003 Jul;70(3):361-72. doi: 10.1002/jmv.10404.
2
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles.丙型肝炎病毒糖蛋白介导假型逆转录病毒颗粒的pH依赖性细胞进入。
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7271-6. doi: 10.1073/pnas.0832180100. Epub 2003 May 21.
3
Tissue culture and animal models for hepatitis C virus.丙型肝炎病毒的组织培养和动物模型
Clin Liver Dis. 2003 Feb;7(1):23-43. doi: 10.1016/s1089-3261(02)00071-5.
4
L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus.L-SIGN(CD209L)是丙型肝炎病毒的肝脏特异性捕获受体。
Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4498-503. doi: 10.1073/pnas.0831128100. Epub 2003 Apr 3.
5
Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR.丙型肝炎病毒糖蛋白与DC-SIGN和DC-SIGNR相互作用。
J Virol. 2003 Apr;77(7):4070-80. doi: 10.1128/jvi.77.7.4070-4080.2003.
6
Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.含有功能性E1-E2包膜蛋白复合物的传染性丙型肝炎病毒假颗粒。
J Exp Med. 2003 Mar 3;197(5):633-42. doi: 10.1084/jem.20021756.
7
DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2.DC-SIGN和L-SIGN是丙型肝炎病毒糖蛋白E2的高亲和力结合受体。
J Biol Chem. 2003 May 30;278(22):20358-66. doi: 10.1074/jbc.M301284200. Epub 2003 Feb 27.
8
Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infection.用抗丙型肝炎病毒E2单克隆抗体进行肝脏免疫组化染色,以评估丙型肝炎病毒感染中的抗病毒治疗及肝移植再感染情况。
J Hepatol. 2003 Feb;38(2):208-14. doi: 10.1016/s0168-8278(02)00389-6.
9
Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection.体内外建立持续感染丙型肝炎病毒的B细胞淋巴瘤细胞系:病毒感染的凋亡效应
J Virol. 2003 Feb;77(3):2134-46. doi: 10.1128/jvi.77.3.2134-2146.2003.
10
Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.丙型肝炎病毒E2糖蛋白与CD81的结合具有毒株特异性,并受到高变区1和高变区2之间复杂相互作用的调节。
J Virol. 2003 Feb;77(3):1856-67. doi: 10.1128/jvi.77.3.1856-1867.2003.